SAB Biotherapeutics, Inc.
Recent Filings
All 402 filings →| Form | Description | Date |
|---|---|---|
| 4 | 4 | Mar 25, 2026 |
| SCHEDULE 13D/A | — | Mar 23, 2026 |
| 8-K | 8-K | Mar 19, 2026 |
| 424B5 | 424B5 | Mar 19, 2026 |
| 424B5 | 424B5 | Mar 17, 2026 |
| SCHEDULE 13D/A | — | Mar 11, 2026 |
| 8-K | 8-K | Mar 10, 2026 |
| 10-K | 10-K | Mar 9, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Sullivan Eddie Joe | Chief Executive Officer | Purchase | 1,740 @ $0.88 | 5,232,304 | Dec 7, 2023 |
| King Michael | CHIEF FINANCIAL OFFICER | Purchase | 5,000 @ $0.90 | 5,000 | Nov 30, 2023 |
| Reich Samuel J | Executive Chairman | Purchase | 11,000 @ $0.89 | 219,001 | Nov 29, 2023 |
| Kropotova Alexandra | Chief Medical Officer | Award / Grant | 275,000 | 275,000 | Mar 14, 2023 |
| Link David Charles | — | Award / Grant | 41,493 @ $1.21 | 57,313 | Dec 7, 2022 |
| Spragens Jeffrey G | — | Award / Grant | 82,987 @ $1.21 | 394,989 | Dec 7, 2022 |
| HAMILTON CHRISTINE E | — | Award / Grant | 82,987 @ $1.21 | 3,111,334 | Dec 7, 2022 |
| HAMILTON CHRISTINE E | — | Purchase | 10,000 @ $0.73 | 4,993,090 | Sep 13, 2022 |
| Sullivan Eddie Joe | CHIEF EXECUTIVE OFFICER | Purchase | 14,000 @ $0.74 | 5,230,564 | Sep 7, 2022 |
| Kropotova Alexandra | Chief Medical Officer | Award / Grant | 300,000 | 300,000 | Jun 6, 2022 |